EOLS
Evolus Inc
Price:  
7.86 
USD
Volume:  
1,181,607.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EOLS Relative Valuation

-208.4%
Upside

As of 2026-09-19, the Relative Valuation of Evolus Inc (EOLS) is (8.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.86 USD, the upside of Evolus Inc based on Relative Valuation is -208.4%.

The range of the Relative Valuation is (5.42) - (11.75) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 8.1x - 20.7x 12.6x
Forward P/E multiples 8.2x - 17.8x 13.2x
Fair Price (5.42) - (11.75) (8.52)
Upside -169.0% - -249.5% -208.4%
7.86 USD
Stock Price
(8.52) USD
Fair Price

EOLS Relative Valuation - Historical P/E Data

Date P/E
2026-09-16 -12.12
2026-09-15 -12.00
2026-09-14 -12.03
2026-09-11 -11.89
2026-09-10 -12.00
2026-09-09 -13.00
2026-09-08 -13.47
2026-09-04 -14.10
2026-09-03 -13.72
2026-09-02 -13.74
2026-09-01 -13.77
2026-08-31 -13.78
2026-08-28 -13.47
2026-08-27 -13.47
2026-08-26 -13.31
2026-08-25 -13.61
2026-08-24 -13.31
2026-08-21 -12.72
2026-08-20 -12.66
2026-08-19 -13.04
2026-08-18 -12.40
2026-08-17 -11.78
2026-08-14 -12.37
2026-08-13 -12.16
2026-08-12 -12.31
2026-08-11 -12.65
2026-08-10 -11.48
2026-08-07 -11.51
2026-08-06 -11.24
2026-08-05 -9.37
2026-08-04 -9.28
2026-08-03 -9.17
2026-07-31 -8.86
2026-07-30 -9.11
2026-07-29 -9.14
2026-07-28 -9.43
2026-07-27 -9.37
2026-07-24 -9.07
2026-07-23 -9.08
2026-07-22 -8.93
2026-07-21 -8.80
2026-07-20 -8.41
2026-07-17 -8.69
2026-07-16 -8.54
2026-07-15 -9.04
2026-07-14 -9.51
2026-07-13 -9.89
2026-07-10 -10.02
2026-07-09 -10.39
2026-07-08 -10.30